Literature DB >> 29407831

Efficient degradation of 2,4-dichlorophenol in aqueous solution by peroxymonosulfate activated with magnetic spinel FeCo2O4 nanoparticles.

Rui Zhou1, Jian Zhao1, Ningfei Shen1, Taigang Ma1, Yu Su1, Hejun Ren2.   

Abstract

Magnetic spinel FeCo2O4 nanoparticles (NPs) were synthesized and proposed as a catalyst of peroxymonosulfate (PMS) for the degradation of 2,4-dichlorophenol (2,4-DCP). The catalyst was characterized by XRD, TEM, XPS, nitrogen adsorption-desorption isotherms, and magnetization curve. In addition, the effects of parameters, such as initial pH, PMS dosage, FeCo2O4 addition, and initial concentration of 2,4-DCP were studied. The results showed that FeCo2O4 NPs exhibit good properties for the degradation and mineralization of 2,4-DCP, achieving 95.8% and 44.7% removal of 2,4-DCP and TOC, respectively, within 90 min under reaction conditions of 4 mM PMS, 0.06 g L-1 FeCo2O4, 100 mg L-1 2,4-DCP, pH = 7.0, and T = 30 °C. Furthermore, SO4- and HO were main radical species in the reaction system was explored. The 2,4-DCP degradation efficiency could reach 91.8% even after FeCo2O4 NPs were used for the fifth run. Moreover, the degradation efficiencies of metronidazole (MNZ), methylene blue (MB), and rhodamine B (RhB) could reach 74.8%, 86.7%, and 96.1% under the same reaction conditions, respectively. Results revealed that the FeCo2O4/PMS system shows potential for degrading contaminants in the environment.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2,4-Dichlorophenol; Degradation; Fe–Co interaction; Peroxymonosulfate; Spinel FeCo(2)O(4)

Mesh:

Substances:

Year:  2018        PMID: 29407831     DOI: 10.1016/j.chemosphere.2018.01.079

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  1 in total

1.  Catalytic degradation of diclofenac from aqueous solutions using peroxymonosulfate activated by magnetic MWCNTs-CoFe3O4 nanoparticles.

Authors:  Yousef Dadban Shahamat; Mohammad Ali Zazouli; Mohammad Reza Zare; Nezamaddin Mengelizadeh
Journal:  RSC Adv       Date:  2019-05-28       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.